Annual Short Term Debt
$4.59 M
+$507.00 K+12.42%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual short term debt is $4.59 million, with the most recent change of +$507.00 thousand (+12.42%) on December 31, 2023.
- During the last 3 years, CTMX annual short term debt has risen by +$1.39 million (+43.63%).
- CTMX annual short term debt is now at all-time high.
Performance
CTMX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$5.00 M
+$140.00 K+2.88%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly short term debt is $5.00 million, with the most recent change of +$140.00 thousand (+2.88%) on September 30, 2024.
- Over the past year, CTMX quarterly short term debt has increased by +$543.00 thousand (+12.18%).
- CTMX quarterly short term debt is now at all-time high.
Performance
CTMX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
CTMX Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +12.4% | +12.2% |
3 y3 years | +43.6% | +12.2% |
5 y5 years | +100.0% | +12.2% |
CTMX Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +26.8% | at high | +38.2% |
5 y | 5-year | at high | +63.3% | at high | +78.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
CytomX Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.00 M(+2.9%) |
Jun 2024 | - | $4.86 M(+2.9%) |
Mar 2024 | - | $4.72 M(+2.9%) |
Dec 2023 | $4.59 M(+12.4%) | $4.59 M(+2.9%) |
Sep 2023 | - | $4.46 M(+3.0%) |
Jun 2023 | - | $4.33 M(+3.0%) |
Mar 2023 | - | $4.20 M(+3.0%) |
Dec 2022 | $4.08 M(+12.8%) | $4.08 M(+3.1%) |
Sep 2022 | - | $3.96 M(+3.0%) |
Jun 2022 | - | $3.85 M(+3.1%) |
Mar 2022 | - | $3.73 M(+3.1%) |
Dec 2021 | $3.62 M | $3.62 M(+3.1%) |
Sep 2021 | - | $3.51 M(+3.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $3.40 M(+3.2%) |
Mar 2021 | - | $3.30 M(+3.2%) |
Dec 2020 | $3.19 M(+13.7%) | $3.19 M(+3.2%) |
Sep 2020 | - | $3.10 M(+3.3%) |
Jun 2020 | - | $3.00 M(+3.3%) |
Mar 2020 | - | $2.90 M(+3.3%) |
Dec 2019 | $2.81 M(>+9900.0%) | $2.81 M(+3.3%) |
Sep 2019 | - | $2.72 M(+3.3%) |
Jun 2019 | - | $2.63 M(+3.4%) |
Mar 2019 | - | $2.54 M(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Jun 2015 | - | $1.25 M(-12.3%) |
Dec 2014 | $1.42 M(+12.8%) | $1.42 M |
Dec 2013 | $1.26 M | - |
FAQ
- What is CytomX Therapeutics annual short term debt?
- What is the all time high annual short term debt for CytomX Therapeutics?
- What is CytomX Therapeutics annual short term debt year-on-year change?
- What is CytomX Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly short term debt year-on-year change?
What is CytomX Therapeutics annual short term debt?
The current annual short term debt of CTMX is $4.59 M
What is the all time high annual short term debt for CytomX Therapeutics?
CytomX Therapeutics all-time high annual short term debt is $4.59 M
What is CytomX Therapeutics annual short term debt year-on-year change?
Over the past year, CTMX annual short term debt has changed by +$507.00 K (+12.42%)
What is CytomX Therapeutics quarterly short term debt?
The current quarterly short term debt of CTMX is $5.00 M
What is the all time high quarterly short term debt for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly short term debt is $5.00 M
What is CytomX Therapeutics quarterly short term debt year-on-year change?
Over the past year, CTMX quarterly short term debt has changed by +$543.00 K (+12.18%)